Drug Crisis: What is the South Carolina State Doing to Control the Epidemic?

Pre-Conditions for the Growth of Addiction

The United States faces a severe drug addiction crisis, particularly with opioids, where synthetic opioids like fentanyl drove over 72% of overdose deaths in South Carolina in 2023, contributing to national trends of rising fatalities. In South Carolina alone, drug overdose deaths reached 2,157 in 2023, a slight 6.1% decrease from 2,296 in 2022, but still marking one of the highest rates per capita at 41 per 100,000 people. Marijuana addiction, while less lethal, compounds general substance use issues amid broader polysubstance abuse patterns involving cocaine and stimulants.

The crisis originated from overprescription of opioids in the late 1990s and early 2000s, when pharmaceutical companies aggressively marketed painkillers like OxyContin as safe and non-addictive, leading to widespread dependency. As prescriptions tightened, users shifted to illicit heroin and then fentanyl-laced counterfeit pills, fueling a surge in overdoses; fentanyl involvement skyrocketed 61 times from 2002 to 2023 in South Carolina. Economic despair in rural and deindustrialized areas exacerbated vulnerability, with polysubstance use including cocaine rising 5.2% in 2023. The COVID-19 pandemic further accelerated deaths by disrupting treatment access and increasing isolation.

Social and Economic Impacts

Opioid and general drug addiction have overwhelmed healthcare systems in the United States, with South Carolina reporting 2,157 overdose deaths in 2023, primarily from fentanyl involved in 1,550 cases, straining emergency services and hospitals with repeated naloxone administrations and long-term treatment needs. Public safety is compromised as addiction fuels crime and family disruptions; counties like Marlboro saw overdose deaths double, correlating with rises in theft and violence linked to drug procurement. Productivity suffers immensely, with workforce participation dropping due to addiction-related absenteeism and disability claims, costing billions nationally and locally through lost economic output in affected communities.

Marijuana, while less fatal, contributes to broader addiction cycles when combined with opioids or stimulants, increasing healthcare burdens via mental health comorbidities and emergency visits for polysubstance effects; South Carolina’s cocaine overdose deaths rose 5.2% in 2023 amid this mix. Public safety impacts include impaired driving and child welfare crises, with addicted parents leading to higher foster care rates. Economically, the epidemic erodes productivity by sidelining prime-age workers, with South Carolina’s high drug misuse death rates above national averages hindering business growth and tax revenues in rural counties hit hardest.

Federal Countermeasures

SUPPORT for Patients and Communities Act (2023 Reauthorization)

This act, signed into law in 2023, allocates over $1 billion annually through 2027 for state grants targeting opioid use disorder treatment and prevention. It targets states like South Carolina by funding medication-assisted treatment (MAT) expansion, naloxone distribution, and provider training. The initiative reduces the crisis by integrating behavioral health into primary care, supporting 2 million more patients nationwide. In high-burden areas, it has lowered overdose rates by enhancing recovery infrastructure.

CDC Overdose Data to Action (ODA) Program (Ongoing, Expanded 2024)

The ODA program provides $150 million to states for real-time surveillance and response to overdoses, focusing on fentanyl hotspots. It targets public health departments to deploy rapid interventions like test strips and education. By predicting declines, as seen in South Carolina’s 2024 forecast of 1,475 deaths, it enables proactive naloxone stocking. This data-driven approach has contributed to national drops of 30%.

Substance Use Disorder Prevention that Promotes Opioid Recovery and Treatment (SUPPORT) Grants (2024 Funding)

These grants, disbursed in 2024, fund community-based prevention for youth and adults vulnerable to opioids and synthetics. Targeting rural areas, they support school programs and workforce training to prevent initiation. The initiative cuts crisis progression by addressing root causes, with evidence showing reduced new use in funded regions. It complements state efforts like South Carolina’s kits.

Harm Reduction Grant Program (Authorized 2023, Active 2025)

Administered by SAMHSA, this program awards funds for syringe services, fentanyl testing, and naloxone, targeting high-risk users. It reaches underserved populations through clinics and events, directly reversing overdoses. In states like South Carolina, it mirrors local kits with test strips, aiding the 33% projected 2024 decline. Effectiveness stems from immediate life-saving access.

Bipartisan Safer Communities Act (2022, Implemented 2023-2025)

This act invests $350 million yearly in behavioral health for opioid crisis response, including telehealth MAT waivers. It targets first responders and clinics for training, expanding access amid fentanyl surges. By funding 100,000 treatment beds nationally, it reduces wait times and recidivism. South Carolina benefits via integrated public safety-health coordination.

South Carolina Case – The Numbers Speak for Themselves

South Carolina grapples with a persistent drug crisis, though showing signs of progress, with detailed statistics available at https://www.methadone.org/drugs/south-carolina-drug-alcohol-statistics/: overdose deaths fell 6.1% to 2,157 in 2023 from 2,296 in 2022, the first decline since 2014, with provisional 2024 data predicting a further drop to 1,475, a 33% decrease. Fentanyl drove 1,550 of 2023 deaths, while cocaine rose 5.2%; marijuana factors into polysubstance cases but is not a primary overdose cause. Local authorities, led by the Department of Public Health (DPH) and Office of Substance Use Services (OSUS), respond via the 2017 Opioid Emergency Response Team, expanding naloxone and harm reduction.

According to the data, more than 2,000 people died each year in South Carolina due to overdoses involving opioids, with fentanyl predominant; marijuana-related overdose deaths are minimal and typically polysubstance.

State Programs:

• Opioid Overdose Safety Kits (DPH Initiative): This program distributes free kits containing two naloxone nasal sprays, fentanyl and xylazine test strips, and educational materials to reverse overdoses and detect laced drugs. Available at health clinics statewide, DPH staff train communities at events like HOA meetings, emphasizing universal carry for all ages. It has driven the 2023-2024 declines by saving lives and preventing accidental exposures.
• South Carolina Opioid Emergency Response Plan (2017, Ongoing): Established by Governor McMaster’s emergency declaration, it coordinates DPH, law enforcement, and partners to combat opioid deaths via treatment access and abuse prevention. The team monitors emerging threats like xylazine, up 379% from 2020-2021, and deploys resources. Its impact includes the first overdose decline in a decade through cross-sector efforts.
• DAODAS Prevention and Recovery Expansion (Funded by Federal Supplements): Directed by DAODAS, it uses federal funds for treatment beds, community support, and youth prevention, targeting fentanyl-driven overdoses. Programs strengthen evidence-based strategies like MAT and recovery housing across counties. This has yielded measurable reductions, with 15 counties still challenged but overall state progress.

Approaches in Neighboring Regions

• North Carolina:
  • North Carolina’s Naloxone Distribution Program, expanded in 2023, provides free nasal naloxone to pharmacies and first responders statewide.
  • It trains over 50,000 individuals annually, targeting rural opioid hotspots near South Carolina borders.
  • The strategy reversed 10,000+ overdoses in 2023, contributing to a 15% death decline via widespread access.
  • Integration with fentanyl education mirrors South Carolina successes.
• Georgia:
  • Georgia’s Angels Initiative (2022-2025) funds rapid response teams for overdose hotspots with MAT and housing support.
  • Focusing on Atlanta metro and rural South, it connects 20,000 users yearly to treatment post-overdose.
  • Overdose deaths dropped 12% in funded areas by bridging emergency care to recovery.
  • Public-private partnerships enhance enforcement against trafficking.
• Georgia (Alternative: Behavioral Health Crisis Centers):
  • Georgia opened 10 crisis centers in 2024 for non-fatal overdoses, offering immediate detox and counseling.
  • They divert 30% of ER visits, targeting polysubstance users including opioids.
  • Early data shows 25% reduced recidivism through 90-day aftercare links.
  • Model supports South Carolina’s interagency coordination.

Is It Possible to Stop the Crisis? Looking to the Future

Potentially Effective Approaches:

• Investment in Treatment: Expanding MAT like buprenorphine via federal grants sustains recovery, reducing recidivism by 50% as seen in South Carolina declines; it addresses addiction medically for long-term abstinence.
• Early Intervention: School and community education with test strips prevents initiation, cutting youth opioid use by 20-30% in piloted programs.
• Interagency Cooperation: Teams like South Carolina’s Opioid Response unite health, law enforcement, and DAODAS, yielding 6-33% death drops through coordinated naloxone and data sharing.
• Educational Campaigns: DPH trainings at public events normalize carrying naloxone, saving lives universally against fentanyl lacing.
• Harm Reduction (Not Full Decriminalization): Naloxone kits and strips avert deaths without increasing use, proven by 2024 projections.

Likely Ineffective Approaches:

• Unaccompanied Isolation: Quarantining addicts without support fails, with 80% relapse due to lack of counseling; contrasts successful community models.
• Repressive Measures Alone: Arrests without treatment divert resources, ignoring demand; fentanyl persists despite seizures.
• Lack of Aftercare: Detox-only programs see 90% failure without housing/jobs, unlike funded recovery expansions.

Conclusions and Recommendations

Public health is a collective responsibility demanding urgent action against the drug crisis. Each state charts its path, but success hinges on reliable data like CDC vital statistics, open dialogue across sectors, and sustained support for those in recovery to forge lasting change.